Back to Search
Start Over
Avadel Pharmaceuticals reports results from Phase 3 REST-ON trial of FT218
- Source :
- The Fly. April 27, 2020
- Publication Year :
- 2020
-
Abstract
- Avadel Pharmaceuticals announced topline data from its pivotal Phase 3 REST-ON trial assessing the safety and efficacy of FT218, an investigational, once-nightly formulation of sodium oxybate for the treatment of [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.622093678